Baby Safety / Compounds / MDI residual (4,4'-methylenediphenyl diisocyanate)

Is MDI residual (4,4'-methylenediphenyl diisocyanate) safe for babies and kids?

Context-dependent for kids

(Babies-specific data is limited; this page draws from human pregnant context.) Pregnancy alters the metabolism and distribution of MDI residual (4,4'-methylenediphenyl diisocyanate), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

What is mdi residual (4,4'-methylenediphenyl diisocyanate)?

The IUPAC name is 1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene.

Also known as: 1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene, 4,4'-Diphenylmethane diisocyanate, Diphenylmethane diisocyanate, Bis(4-isocyanatophenyl)methane.

IUPAC name
1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene
CAS number
101-68-8
Molecular formula
C15H10N2O2
Molecular weight
250.25 g/mol
SMILES
O=C=NC1=CC=C(CC2=CC=C(C=C2)N=C=O)C=C1
PubChem CID
7570

Risk for babies

Context-dependent

Pregnancy alters the metabolism and distribution of MDI residual (4,4'-methylenediphenyl diisocyanate), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of MDI residual (4,4'-methylenediphenyl diisocyanate), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

5 regulatory and scientific bodies have classified MDI residual (4,4'-methylenediphenyl diisocyanate). The classifications differ — that's the data.

AgencyYearClassificationNotes
EPA CTX / IRIS—D (Not classifiable as to human carcinogenicity)
EPA CTX / IRIS—Carcinogenic potential cannot be determined
EPA CTX / IARC—Group 3 - Not classifiable as to its carcinogenicity to humans
EPA CTX / Genetox—Genotoxicity: positive (Ames: positive, 2 positive / 6 negative reports)
EPA CTX / Genetox—Genotoxicity: positive (Ames: positive, 2 positive / 6 negative reports)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter mdi residual (4,4'-methylenediphenyl diisocyanate)

  • Industrial Facilities — Manufacturing plants, Waste treatment sites
  • Occupational Environments — Factories, Warehouses

Safer alternatives

Lower-risk approaches that achieve a similar outcome to MDI residual (4,4'-methylenediphenyl diisocyanate):

  • Bio-based polymer alternatives where available
    Trade-offs: Performance limitations. End-of-life complexity.
    Relative cost: 2-5× conventional

Frequently asked questions

What products contain mdi residual (4,4'-methylenediphenyl diisocyanate)?

MDI residual (4,4'-methylenediphenyl diisocyanate) appears in: Manufacturing plants (Industrial facilities); Waste treatment sites (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

Why do regulators disagree about mdi residual (4,4'-methylenediphenyl diisocyanate)?

MDI residual (4,4'-methylenediphenyl diisocyanate) has been classified by 5 agencies including EPA CTX / IRIS, EPA CTX / IRIS, EPA CTX / IARC, EPA CTX / Genetox, EPA CTX / Genetox, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See MDI residual (4,4'-methylenediphenyl diisocyanate) in the baby app

Look up products containing mdi residual (4,4'-methylenediphenyl diisocyanate), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (3)
  1. PubChem Compound CID 7570 — database
  2. EPA CompTox Chemicals Dashboard — DTXSID7025180 — epa
  3. ATSDR Toxicological Profile — CAS 101-68-8 — reference

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →